The revival of Phage Therapy to fight Antimicrobial Resistance – Part I: What are the legal implications?

Keyphrases

• Allergy Disease 7%
• Antibiotic Resistance 7%
• Antibiotics 23%
• Antimicrobial Resistance 100%
• Bacterial Targets 7%
• Bacteriophage 7%
• Bell 7%
• Beneficial Effects 7%
• Broad-spectrum Antibiotics 7%
• Clinical Research 7%
• Delinkage 7%
• Drug Treatment 7%
• European Commission 7%
• European Union 23%
• Failure Risk 7%
• Far-western Blotting 7%
• Gastrointestinal Diseases 7%
• Georgia 7%
• Human Infection 7%
• Infectious Diseases 7%
• Influenza Vaccine 7%
• Intellectual Property Protection 7%
• June 2014 7%
• Legal Challenges 7%
• Legal Implications 100%
• Marketing Approval 7%
• Multicenter Clinical Trial 7%
• Negative Consequences 7%
• News Reporting 7%
• Phage 46%
• Phage Therapy 100%
• Pharmaceutical Companies 7%
• Phase II Trial 7%
• Private Investment 7%
• Private Involvement 7%
• Private-public Partnership 7%
• Public Perception 7%
• Reasons to Believe 7%
• Regulatory Agencies 7%
• Safety Concerns 7%
• SarA 7%
• Scientific Councils 7%
• Treatment of Bacterial Infections 7%
• Viral 7%
• Virus 23%
• Western Experience 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Antibiotics 20%
• Antimicrobial Resistance 100%
• Bacterial Infection 5%
• Bacteriophage 100%
• Burn 5%
• Clinical Research 5%
• Clinical Trial 5%
• Diseases 5%
• Gastrointestinal Disease 5%
• Infection 10%
• Influenza Vaccine 5%
• Pharmacotherapy 5%
• Side Effect 5%